Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects: |Thyrotoxicosis and Hyperthyroidism |Thyroid Storm - Thyrotoxic crisis |Graves Disease (Thyrotoxicosis) |Amiodarone and Thyroid disease |Thyroid Surgery (Thyroidectomy) |Hypothyroidism |Hashimoto's thyroiditis |DeQuervain's thyroiditis |Subacute Thyroiditis |Thyroid nodule |Congenital Hypothyroidism |Thyroid Function Tests and antibodies |Post partum thyroiditis |Sick Euthyroid Syndrome |Thyroid Exam (OSCE) |Thyroid Gland anatomy and Physiology |Thyroid Cancer
β οΈ Postpartum thyroiditis may be misdiagnosed as postnatal depression β always consider TFTs in new mothers with fatigue, mood changes, or unexplained physical symptoms.
Check thyroid function in high-risk groups:
| Diagnosis | TSH | T3 | T4 |
|---|---|---|---|
| Hypothyroid (primary) | High | - | Low |
| Treated hypothyroid | High | - | Normal |
| TSH-secreting tumour | High | - | High |
| Slow T4βT3 conversion | High | Low | High |
| Hyperthyroid | Low | High | High |
| Subclinical hyperthyroid | Low | Normal | Normal |
| Central hypothyroid | Low | - | Low |
| Sick euthyroid / pituitary disease | Low | Low | Low |
| Assay/drug effect (e.g. amiodarone) | Normal | - | Abnormal |
π‘ Interpretation pearl: In primary thyroid disease, TSH and T4 move in opposite directions. In central disease, TSH and T4 move in the same direction.